Lactobacillus johnsonii provides a dose-dependent protection against UVR-induced immunosuppression.
Audrey
A
Guéniche
Timo
T
Buetler
Jalil
J
Benyacoub
Stephanie
S
Blum
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003877:Dermatitis, Contact / Q000276:immunology*; D004195:Disease Models, Animal; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D007108:Immune Tolerance / Q000187:drug effects*; D007778:Lactobacillus; D051379:Mice; D008812:Mice, Hairless; D011208:Powders / Q000494:pharmacology; D014466:Ultraviolet Rays / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D011208:Powders